Basal Health Review
Best for: Patients who want a metabolic-framework framing of GLP-1 therapy alongside lifestyle markers (insulin sensitivity, lean mass, VO2 max, body fat) — not just a single-product checkout. Pricing is opaque before consultation.
Basal Health (basal.health) is a national GLP-1 telehealth platform with a metabolic-medicine framing. The marketing positions GLP-1 therapy as one piece of a 5-marker metabolic framework — insulin sensitivity, muscle mass, hormonal response, VO2 max, and body-fat percentage — and emphasizes clinician-supervised dosing rather than a single-product checkout. Stated coverage: all 50 U.S. states plus the District of Columbia. GLP-1 molecules are not named on public marketing pages — the site describes 'clinically appropriate' GLP-1 selection and a 'compounding pharmacy partner' relationship without naming the 503A facility or disclosing per-dose pricing. Pricing is not surfaced publicly; patients receive a treatment plan after intake review. No LegitScript badge visible on the homepage. No FDA compounded-medication disclaimer surfaced on the marketing pages reviewed. Verbatim positioning: 'Metabolism is the signal. The signal is broken.' Live-verified 2026-05-24.
Medium confidence · Last verified 2026-05-24 via Eli Marsden · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Basal Health is a solid telehealth option with balanced features and pricing.
Score Breakdown
✓ Pros
- •Stated nationwide coverage (50 states + DC)
- •Metabolic-framework positioning rather than single-product
- •Clinician-supervised dosing rather than fixed protocol
- •Adaptive monitoring framing
✗ Cons
- •**No pricing surfaced publicly** — patients must complete intake to see cost
- •**Compounding pharmacy partner not named** — 503A facility identity not disclosed
- •**GLP-1 molecules not specified** on public marketing (semaglutide vs tirzepatide vs oral)
- •**No LegitScript verification badge** visible on homepage
- •**No verbatim FDA compounded-medication disclaimer** surfaced on marketing pages reviewed
- •Named medical director not disclosed
Ready to start with Basal Health?
See current pricing and start your free consultation.
Sources & methodology
Our Basal Health review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
Alternatives to Basal Health
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Basal Health?
See current pricing and start your free consultation.